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ABSTRACT 
 
In the present work, an exhaustive review of the main developments and applications of 
capillary electrophoresis-mass spectrometry (CE-MS) for peptide analysis is given. This 
review includes the use of different CE separation modes, MS analyzers, capillary 
coatings, preconcentration techniques, on-chip applications as well as other different 
multidimensional strategies for peptide analysis. Key applications are critically 
discussed and relevant works published from January-2000 to May-2007 are 
summarized including information concerning the type of sample, CE-MS parameters 
as well as some figures of merit of the different CE-MS procedures developed for 
peptide analysis and peptidomics. 
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1. INTRODUCTION 
 
In the “omics” era, information provided by proteomics and peptidomics is of great 
importance considering that proteome and peptidome, in contrast to genome, are 
constantly changing and related to each other through complex networks. Peptidomics 
is defined as the analysis of the peptide content within an organism, tissue, or cell. 
Technically this definition includes all peptides present in the system, including 
transient products of protein degradation [1].  
 
Analysis of peptides has a huge importance in many other areas apart from peptidomics. 
Thus, the method commonly employed to unequivocally identify a given protein 
consists of obtaining its peptidic fragments, usually by well-known enzymatic reactions, 
followed by peptide sequencing by different analytical strategies. However, analysis of 
peptides in real samples (including the mentioned proteomics or peptidomics studies) is 
not an easy task, mainly due to their low concentration and the huge number of different 
peptidic sequences that can become available. 
 
The key element of the classical proteome research combines the multidimensional 
separation of proteins from a complex mixture through 2D-gel electrophoresis [2] and 
their identification by mass spectrometry (MS) [3]. Concerning peptide analysis and 
peptidomics, the use of 2D-gel electrophoresis in many cases does not provide adequate 
separations and, therefore, other alternative methods have been developed including the 
use of classical Edman sequencing, HPLC-MS and, more recently, MALDI-TOF-MS 
and capillary electrophoresis-mass spectrometry (CE-MS) [4]. Analysis of peptides by 
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these procedures has become a key analytical step and its use includes applications in 
clinical diagnosis, drug discovery, food analysis, etc. 
 
CE-MS has become a powerful hyphenated technique for the separation and 
identification of peptides, mainly due to the particular characteristics provided by CE, 
that is, high efficiencies, fast analysis times, low sample and reagents consumption and  
versatility considering the different CE modes available. The increasing use of this 
coupling technique can be inferred by the high number of reviews published involving 
the use of CE-MS for proteins and peptides analysis [5-12] as well as for other 
biomolecules [7,13-15] or more general CE-MS developments and applications [16-23]. 
 
The aim of this work is to critically describe the main applications of CE-MS for 
peptide analysis and peptidomics published from January-2000 to May-2007. Thus, 
some representative applications are discussed trying to cover all available CE 
separation modes, MS analyzers and interfaces employed. Also the use of different 
capillary coatings, pre-concentration techniques, on-chip applications as well as other 
different multidimensional strategies have been included, ending with some outlooks on 
the future developments and applications of CE-MS in this growing area.   
 
2. COUPLING CE WITH MS. 
 
2.1. Electrospray interface (ESI). 
 
Electrospray [24] is, at the moment, the interface most frequently used to carry out CE-
MS [25], since this soft ionization method allows the direct transfer of the analytes from 
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CE to MS and provides a relatively easy way to close the electrical circuit that CE needs 
to operate. Besides, taking into account the MS analysis of large peptides, this 
ionization technique allows the formation of multi-charged ions which is very useful 
considering that some MS analyzers have a limited mass range. In spite of these 
advantages, two problems still have to be solved to successfully establish this coupling. 
Firstly, it is usually necessary to increase the liquid flow coming from the separation 
capillary (nl/min) to higher values for the formation of stable spray (1-200 μl/min). 
Secondly, an additional limitation has to be considered regarding the high volatility 
required of the compounds used in the background electrolyte in order to make them 
compatible with the spray formation. To overcome these problems, three different ESI 
interfaces have been developed: sheath flow, sheathless and liquid-junction interfaces, 
that are briefly commented below.  
 
2.1.1. Sheath-flow interface. 
 
The use of a sheath liquid in the interface was firstly proposed by Smith and co-workers 
[26], and basically consist on the use of three coaxial tubing that supply the analytes, the 
nebulization gas and the sheath liquid. The sheath liquid will have two different 
functions since it will act as an additional flow to enhance the spray and besides, it will 
close the electric contact at the outlet of the capillary acting as the second electrode. By 
using this set up stable sprays are obtained. Besides, it presents great versatility since a 
great variety of buffers can be used. Likewise, although the robustness of this set up is 
higher compared to other systems, the sensitivity is lower due to the dilution of the 
analytes by the sheath liquid. However, this is the most used interface [17] and is the 
only one that is commercially available. Nilsson et al. [27] carried out an interesting 
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work based on the use of chemometric tools to evaluate the influence of several 
parameters when using a sheath flow interface. To do that, they employed several 
standard peptides concluding that the selection of the sheath liquid flow had a direct 
influence on the separation efficiency, while the nebulizing gas flow was related to the 
noise level generated. Interestingly, these relationships behaved similarly when 
comparing 25 μm and 50 μm capillaries, although it was possible to obtain better 
sensitivity with the narrower capillaries. Moreover, higher efficiencies were measured 
when using the 25 μm ID capillaries combined with low sheath flow rates (ca. 2.0 
μl/min). 
 
2.1.2. Sheathless interface. 
 
In this kind of interface, the electrical contact is established without the intervention of 
an additional flow. Instead, to close the electrical contact, different strategies have been 
tried, including the coating of the tip end of the capillary with a conductive metal, 
generally gold or silver, or with a polymer, and the introduction of a conductive wire 
inside the outlet of the capillary to act as the electrode. Nevertheless, the absence of 
commercial devices has brought about a good number of papers on this topic proposing 
different solutions. Thus, Waterval et al. [28] studied 5 different approaches to interface 
CE and MS without the use of sheath flow or nebulizing gas. These approaches 
basically consisted of different conductive spray tips and a T-junctions containing a 
gold wire as electrode. They applied these junctions to the analysis of different large 
peptides (insulin and cytochrome c) and concluded that the most robust interface was 
the T-junction, being possible to detect these peptides together with an on-line 
preconcentration step at amounts as low as fmol. Besides, the influence of the inner 
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diameter of the spray tip on the MS signal was carefully studied, concluding that it was 
a critical parameter for the spray formation. 
 
There are currently published many interesting applications on the analysis of peptides 
using CE-MS with a sheathless interface [29-33], demonstrating that very high 
sensitivities can be obtained with detection limits as low as a few attomoles [32]. 
However, although this kind of interface is in general more sensitive than the sheath-
flow interface, the problems related to the manufacturing of these sheathless devices, 
together with their low robustness and reproducibility have to be also considered. This 
fact was clearly demonstrated by Sanz-Nebot et al. [34]. A comparison between a 
sheathless interface based on a graphite coated tip and a sheath-flow interface revealed 
that the reproducibility found with the sheathless interface was, by far, lower than that 
determined using the sheath-flow interface, while the LODs values were similar [34]. 
Moreover, the formation of the spray in these sheathless devices is directly related to the 
presence of a strong electroosmotic flow, which in many cases can reduce spray 
stability or, directly, to preclude its application. 
 
2.1.3. Liquid junction interface. 
 
The third ESI interface, denominated liquid junction interface [35], is based on the use 
of an additional electrolyte reservoir that provides the electrical connection. In this case, 
the formation of the spray is obtained through an emitter capillary positioned following 
the outlet of the separation capillary, separated by a short space (10-20 μm). The main 
advantage of this device is that provides independent control of the CE separation and 
the electrospray. On the other hand, its main drawback is the difficulty to carry out 
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reproducible junctions between the emitter and separation capillary, giving frequently 
rise to peak broadening and loss of separation efficiency.  
 
Foret and co-workers [36] developed a subatmospheric interface that used a liquid 
junction with a replaceable micro-ESI tip. The low pressure inside the ESI region leaded 
to sample transport through the ESI needle without the need for positive pressure at the 
liquid junction. Using cytochrome c tryptic digests, the authors could confirm the 
sensitivity improvement compared to the standard sheath flow interface, with limits of 
detection in the attomole range. More recently, Fanali et. al [37] employed a liquid 
junction interface in which the flow of the spray liquid was hydrostatically induced by 
gravity from a small electrolyte reservoir. Under these conditions the CE-MS system 
generated an efficient, reproducible and stable electrospray resulting in good sensitivity 
values that allowed the detection of ng/ml of peptides. However, in authors’s opinion, 
additional performance enhancement should still be possible with the use of narrower 
electrospray tips. 
 
3. MS analyzers. 
 
Concerning the analysis of peptides by CE-MS, a high variety of mass analyzers have 
been used, mainly single quadrupole (Q), triple quadrupole (QqQ), ion trap (IT) and 
time of flight (TOF), as well as other more expensive systems as quadupole-time of 
flight MS [38-40], Hadamard transform time-of-flight MS [41], Fourier transform ion 
cyclotron resonance MS (FTICR-MS) [17,42-44], etc. However, the employment of 
these advanced MS analyzers is not so common, obviously due to their high price and 
more difficult operation routine. 
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Quadrupoles, due to their lower price, small size and simplicity of operation, are among 
the mass analyzers most employed for CE, however, their low resolution and modest 
sensitivity and mass range are often a drawback for peptide-related research. TOF mass 
analyzers are more powerful than quadrupoles regarding duty cycle (scanning speed), 
resolution, sensitivity and mass range, and thus, TOF analyzers are becoming more 
extensively employed for CE-MS of peptides [17]. However, at present, TOF analyzers 
are more expensive than the relatively simple quadrupoles or ion traps (IT) analyzers. 
Thus, ITs are also becoming widely used for CE-MS analysis of peptides since these 
analyzers can provide enough scanning speed and sensitivity. Besides, with IT it is also 
possible to carry out MS/MS experiments, which is particularly interesting for peptide 
sequencing. 
 
In a work by Zürbig et al. [45], several MS analyzers combined with CE have been 
compared to identify polypeptidic biomarkers, including off-line CE-MALDI-TOF-MS 
that is out of the scope of the present review. Among the CE-ESI-MS on-line couplings 
studied in that work, authors demonstrated that the best results were obtained using the 
FTICR device, while QTOF analyzer allowed a successful sequencing of polypeptides 
and provided better results than simpler MS analyzers such as IT. 
 
4. CE SEPARATION MODES FOR THE ANALYSIS OF PEPTIDES. 
 
Three main modes have been employed so far to analyze peptides by CE-MS, namely, 
CZE, CIEF and CEC. Other modes, as MEKC and CGE are either, not compatible or 
not appropriate to separate peptides.  
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4.1. CZE-MS. 
 
Capillary zone electrophoresis (CZE, also called free solution capillary electrophoresis) 
is by far the most employed CE mode for CE-MS analysis of peptides. Peptides are 
easily separated in CZE based on their different charge/mass ratios [46] selecting MS 
compatible background electrolytes (BGE) usually composed of formic acid, acetic acid 
and/or ammonium hydroxide. In this sense, there is a huge number of CE-MS works in 
which this simple CZE mode is used together with a BGE at low pH (pH 2–3.5) to 
separate and analyse peptides bearing a global positive charge [47-48]. 
 
4.2. CEC-MS. 
 
Capillary electrochromatography (CEC) can be considered as an hybrid technique 
combining characteristics from HPLC and CE. Under this CE mode, analytes are 
separated by the same principles as in HPLC but the driving force is, in this case, the 
electroosmotic flow. This mode is less employed than CZE due to the complexity of 
fabrication and use of the CEC columns, their price and low robustness, mostly when 
working with real samples. On the positive side, CEC allows the use of highly MS-
compatible BGEs and provides the separation of neutral and charged compounds 
through their interaction with the stationary phase, as also demonstrated for peptides 
[49]. Thus, Gucek et al. [32] were able to obtain sensitivity values in the attomole range 
for different selected peptides coupling CEC to MS using a conductively coated tip at 
the end of a C18 packed CEC column. With this set-up the authors were able to obtain a 
stable spray without using any additional sheath liquid.  
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4.3. CIEF-MS. 
 
Capillary isoelectric focusing (CIEF) is a high resolution technique for the separation of 
proteins and peptides, as well as other amphoteric compounds. Peptides are separated in 
CIEF according to their pI values in a pH gradient formed by carrier ampholytes under 
the effect of an electric voltage. In this sense, the low volatility of these ampholytes 
represents a problem for the MS coupling and different approaches have been proposed 
to overcome this limitation [50]. For instance, in a work by Kuroda et al [51] CIEF-MS 
was employed to quantify human peptides. In that work, the concentration of the carrier 
ampholytes was optimized as a compromise between the optimum resolution and the 
optimum ESI-MS ionization efficiency obtaining limits of detection ten times lower 
than those achieved using UV detection. 
 
5. APPLICATIONS OF CE-MS IN PEPTIDE ANALYSIS. 
 
Some representative applications have been summarized in Tables 1, 2 and 3, classified 
according to the type of interface employed (sheath flow, sheathless and liquid junction, 
respectively). In each table other information is provided including sample description, 
MS analyzer employed, BGE used, sheath liquid nature (if any), capillary coating (when 
available), as well as LOD when data was provided. Finally, in Table 4, the applications 
including microdevices are also summarized. As can be deduced from these tables, most 
applications have been carried out studying peptide standards, since usually this is the 
type of sample selected when developing new instrumental set-ups for CE-MS [79,86]. 
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Besides, in order to make easier the description of the multiple methods developed to 
analyze peptides by CE-MS in the period 2000-2007, the numerous published works on 
this topic will be discussed and classified below considering: i) type of capillary or 
coating, ii) preconcentration technique, iii) use of chips, iv) use of other 
multidimensional strategies.  
 
5.1. CE-MS using bare fused silica capillaries. 
 
Due to its simplicity, CE-MS applications using bare fused silica capillary are numerous 
as it can be deduced from Tables 1, 2 and 3. Among these applications, CE-MS has 
demonstrated to be a powerful technique also for peptidomics. Thus, one of the main 
applications of peptidomics is the biomarkers discovery. Peptides can reveal some 
ongoing organism malfunctions or diseases as already demonstrated [8]. Therefore, the 
discovery of new biomarkers that could help to the diagnosis process is of great interest. 
Several works have been carried out with this aim [45,60,70,74,75,98,99]. Thus, Kaiser 
el al. [74] were able to establish a polypeptide pattern in human fluid samples 
comprising more than 1000 polypeptides within 45-60 minutes analysis times by means 
of a CE-ESI-TOF instrument. To carry out the serum and urine analysis by CE-MS a 
background electrolyte containing 30% methanol, 0.5% formic acid and 69.5% water  
(v/v/v) was selected. The same solution was employed as additional sheath flow in the 
interface employed. Besides, by using a specially designed software, to quickly and 
automatically deconvolute MS spectra, it was possible to establish normal polypeptide 
patterns, which significantly differed from the patterns found in patient samples (Figure 
1). However, the comparison between patients affected by the same disease did not 
reveal any single polypeptide that could act as biomarker for these diseases. 
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Nevertheless, the study of the patterns could indicate differences not only between 
particular diseases but also for the stage of a disease. Therefore, CE-MS was shown as 
as a powerful analytical tool that could greatly help to unequivocal diagnosis based on 
the study of polypeptide patterns [100].  
 
One of the main uses of CE-MS in proteomics/peptidomics research, is protein 
identification through the analysis of the peptides produced after enzymatic digestion of 
the biopolymer [101], including the study of protein modifications [102]. In this regard, 
an important limitation arises from the frequent generation of unexpected peptidic 
fragments during the enzymatic digestion of any protein. To solve this problem, the use 
of theoretical models to simulate peptide behaviour in CE can be very useful 
[47,48,66,70]. Our group has developed a theoretical model to effectively relate the 
peptide sequence to their electrophoretic behaviour [47]. The effectiveness of this model 
was demonstrated by the fast attainment of good CZE-MS conditions for analyzing in a 
single run all the peptides obtained from the enzymatic digestion of a protein, as it can 
be observed in Figure 2. In general, good agreement was obtained between the 
theoretically predicted CE-MS electropherogram and the experimental separation. Thus, 
the simulation program not only provided with adequate background electrolyte for the 
separation but also with accurate information that enabled faster and easier peak 
assignment. This approach was later applied to the study of the equivalence of natural 
and recombinant enzymes, by comparing their cleavage specificities [56], 
demonstrating that this strategy could be a great help for other proteomic studies 
involving CE-MS analysis of peptides. 
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Besides the aforementioned applications, the use of CE-MS together with bare silica 
capillaries has demonstrated to be a very useful analytical tool for studying peptide 
hormones [76] as well as for the characterization of therapeutically important proteins 
through their peptides analysis [55] or even for the quantification of natural bioactive 
peptides in seeds [58]. Other groups have directed their attention to the identification of 
microorganisms by means of peptide analysis of the proteins derived from them [53,73], 
demonstrating that CE-MS can also be used to identify different microorganisms 
present in different matrices even in low amount. Besides, Erny and Cifuentes [104] 
developed a CE-MS mapping approach to obtain 2D maps of protein digests that 
allowed easy and simultaneous visual inspection of large dataset as well as to observe 
immediately relevant differences in closely related samples. In fact, the authors were 
able to differentiate in an easy way different tryptic digests from bovine, rabbit and 
horse cytochrome c. 
 
The use of non-aqueous capillary electrophoresis (NACE) applied to peptidomics is not 
extended. Generally, peptides are relatively hydrophilic compounds that are analyzed by 
CE using aqueous BGEs. However, the use of organic solvents in the BGE could add 
some advantages to the CE-ESI-MS separation procedure, mainly increasing their 
volatility in the interface and the possibility to explore other interactions that do not take 
place in aqueous solutions. Thus, the use of organic solvents for the separation of 
hydrophobic peptides has already been described for the analysis of biologically active 
peptides from fungi [59]. In that work, using a background electrolyte composed by 
12.5 mM ammonium formate in methanol and a sheath flow interface (using as sheath 
liquid 2-propanol:water (1:1, v/v) containing 1% (v/v) formic acid) it was possible to 
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carry out the CE-MS identification of peptides derived from alamethicin F30 and to 
elucidate the amino acid sequence. 
 
5.2. CE-MS using coated capillaries. 
 
A huge number of capillary coatings have been developed up to now for CE analysis of 
peptides and, mostly, proteins [10,105-108]. These capillary coatings are employed to 
eliminate any adsorption of solutes onto the capillary wall and/or to control the 
electroosmotic flow. Coatings are classified in three groups: covalent, physically 
adsorbed and dynamic coatings. Considering the negative effect on the ionization step 
from the non-volatile compounds employed as dynamic coatings, their use in CE-MS is 
not extended [8]. Therefore, covalent and physically adsorbed coatings are the most 
frequently used in combination with CE-MS being neutral polymers usually the first 
choice. In this regard, since neutral polymers suppress the eletroosmotic flow, these 
neutral coatings are usually employed in CE-MS using a sheath flow interface, since, as 
already mentioned above, this interface is less dependant on the EOF. For instance, 
linear polyacrylamide has been used as coating for peptide analysis by CE-MS [67], as 
well as poly(vinyl alcohol) (PVA) [37,57,73,85] demonstrating its suitability to prevent 
peptides adsorption during the analysis of these molecules. In fact, Hu et al., [73] 
showed that it was possible to identify using PVA-coated capillaries and CE-MS/MS, 
common pathogen microorganisms in clinical diagnosis by means of the selective 
identification of some of their specific peptides selected as biomarkers. The authors 
developed a method that included culturing followed by proteins digestion and CE-
MS/MS analysis in about 8 hours. This procedure allowed the identification of different 
pathogens in several samples [73]. 
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Capillary coatings can also have an additional function as stationary phases. This was 
the case of a high-molecular-weight polymer made of linear poly(vinylamine) (PVAm). 
This polymer has been used as a coating and stationary phase conferring positive charge 
to the inner capillary surface to be employed in CEC [96]. The same can be applied to 
other compounds. For instance, different alkylaminosilyl monomers have been found 
useful as coatings for peptide separations in both CZE and CEC [91]. The positively 
charged coatings prevented effectively peptides adsorption onto the inner wall and, at 
the same time, by increasing the alkyl chain lengths of the used monomer, it was 
possible to modify their chromatographic behaviour.   
 
Development of new coatings can enlarge the number of applications of CE-MS 
including analysis of peptides [80,109-111]. In this sense, Bergquist and co-workers 
[71] used the cationic polymer poly-LA 313 as physically adsorbed coating for the CE-
MS analysis of basic peptides. The coating developed was stable in a broad range of pH 
(pH 2-10) even in the presence of organic modifiers. A sheath flow interface was 
employed using a solution containing 20% of 10 mM formic acid (used as BGE) and 
80% of isopropanol (v/v) was used to perform the coupling between the CE instrument 
and the TOF analyzer employed. Using the whole optimized procedure limits of 
detection down to 0.3 μM for methionine-enkephalin were achieved. The same group 
had previously developed a coating, based on a similar polycationic polymer, that was 
shown to work in a shorter pH range (from 4 to 8) [43,84].  
 
Noncovalent bilayer coatings are physically adsorbed coatings that are prepared by 
successive rinsing the capillary using a positively charged polymer solution followed by 
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a negatively charged polymer solution. An example of these coating, is the one formed 
by polybrene (PB) and poly(vinyl sulfonate) (PVS). The suitability of this PB-PVS 
coating in CE-MS/MS has been demonstrated analysing a protein digest [61]. The use 
of this coating allowed separation of peptides from cytochrome c using an acidic 
background electrolyte (500 mM formic acid, pH 2.5) an a sheath flow interface (sheath 
liquid ACN–water–formic acid, 75:25:0.1 v/v/v). Nevertheless, the present coating 
could be successfully used together with sheathless interfaces since it is possible to 
obtain also relatively high and pH-independent EOFs. 
 
5.3. CE-MS using on-line preconcentration techniques. 
 
One of the most important issues regarding peptidomics by CE-MS is to get an adequate 
sensitivity to successfully carry out this kind of analysis, mainly given the typical low 
concentrations of these peptides in real samples. The good sensitivity provided by MS 
instruments is limited in the CE-MS coupling, due to several factors. Firstly, very low 
sample volumes (few nl) can be injected inside the capillary without affecting the 
efficiency and resolution of the separation, and as a consequence, a very small amount 
of analyte reaches the ESI interface. Secondly, the frequent need of additional sheath 
liquids to obtain a stable spray diminishes the sensitivity since some dilution takes 
place. Third, the ionization yield and solute transfer to the MS analyzer have to be also 
considered since in general some loss is observed. 
 
To overcome these limitations, different strategies to preconcentrate the sample before 
ESI-MS analysis have been developed and applied in the field of CE-MS of peptides. 
One of the most popular preconcentration procedures is sample stacking. Thus, it has 
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been shown how introducing a simple pH-mediated stacking step together with low 
sheath flow rates (1-2 μl/min) it was possible to obtain, using sheath flow interfaces, 
sensitivity values close to those reached with a sheathless interface providing LOD 
values at the low nM range for a group of standard peptides [52].  
 
On-line pre-concentration devices based on solid phase extraction (SPE) have also been 
employed for peptide analysis [28,69,82,89,112]. Thus, Janini et al. [79], achieved using 
one of these devices LODs as low as 500 amol for a standard peptides mixture using a 
20 μm ID capillary. The new design developed can be observed in Figure 3. The whole 
device included a miniaturized micro SPE cartridge that was attached near the injection 
end. The whole separation procedure could be completed in less than 15 min, and the 
cartridge could be easily replaced if necessary.  
 
Other preconcentation method employed in peptidomics has been field amplified 
sample injection [62,72]. This technique, first introduced by Chien and Helmer [113] is 
based on the use of two different buffer solutions, usually at the same pH and different 
concentrations, to fill the separation capillary. Under these conditions, a drop in the 
migration velocity of the analytes as they reach the zone between the low conductivity 
sample zone and the high conductivity background electrolyte is achieved. As a result of 
this injection procedure, more than 3000-fold sensitivity enhancement was obtained, 
being possible to detect subnanomolar concentration ranges for the peptides studied 
[62,72]. Recently, the possibility to carry out a field amplified separation using all the 
capillary has been demonstrated by our group [114]. 
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An additional strategy to overcome the low sensitivity problem in CE-MS is the use of 
transient isotachophoresis (transient-ITP). By using this technique, is possible to 
increase the injection volume significantly without losing efficiency and resolution. 
Using this technique Larsson and Lutz [67] were able to increase the injection volume 
up to 0.9 μl while applying this concentration procedure to the qualitative analysis of 
tryptic digests and to the quantitative analysis of several endogenous peptides. 
 
A more complex approach was followed by Kato el al. [64] who developed an 
integrated pepsin coating that enabled the on-line protein digestion, peptide separation 
and protein identification. The authors employed the sol-gel technology to 
photopolymerize a small portion at the beginning of the separation capillary. Then 
pepsin was encapsulated into this gel matrix without losing its enzymatic activity and 
the resulting peptide fragments could be directly separated in the portion of the capillary 
where no monolith existed. To avoid peptides adsorption onto this portion, an acidic 
background electrolyte was used (0.5 M formic acid).  
 
5.4. Chip-based CE-MS applications. 
 
New CE-MS developments based on chips is also a growing field since miniaturization 
is nowadays attracting a wide attention from the scientific community. Typically, CE on 
a chip can provide great flexibility to combine different analytical steps, much shorter 
analysis times, lower sample and reagents consumption and high throughputs [115]. 
Simultaneously to this large interest on chip systems, new devices are being developed 
to couple them to MS instruments. Applications regarding on-chip CE-MS analysis of 
peptides are summarized in Table 4.  
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Thus, one of the first on-chip CE-MS approaches was developed by Karger and co-
workers [97] showing a novel design including sample inlet ports, separation channel, 
liquid junction to interface chip and MS and a guiding channel for the insertion of the 
electrospray capillary. In this case, peptides were elected to test the performance of the 
developed device. A diagram of this device can be observed in Figure 4. It was possible 
to obtain fast separations (50 seconds) in a 4.5 cm on-chip separation channel. A 
subatmospheric electrospray interface was used and LODs in the attomole region were 
achieved.  
 
Other devices have been constructed combining the characteristics from microchip-CE 
and new coatings for peptide analysis. Dahlin at al. [94] coated with an aliphatic 
polyamine agent a chip device, in which an integrated ESI tips were directly fabricated 
by casting PDMS in a mould. Besides, a variety of different coating procedures were 
also evaluated for the outside of the emitter tip. Dusting graphite on a thin 
unpolymerized PDMS layer followed by polymerization was proven to be the most 
suitable procedure, since the emitter tips showed excellent electrochemical properties 
and durability. With this optimized device CE-ESI-MS separations of peptides were 
carried out within 2 min using the hybrid PDMS chip resulting in similar efficiencies as 
for fused silica capillaries of the same length and thus with no measurable band 
broadening effects originating from the PDMS emitter. 
 
5.5. Other multidimensional strategies. 
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Several works have been devised integrating a multidimensional approach in which CE-
MS is included. Multidimensional separations prior to MS detection are likely to be 
increasingly popular [10] since the combined use of two different techniques could not 
only increase the peak capacity but also increase the amount of information collected. In 
this section some recent works in the field of peptide analysis, including a 
multidimensional approach in which the latter dimension implies the use of CE and MS 
detection are commented, although other works including CE and MS not on-line 
coupled can also be found elsewhere [116]. 
 
Cao and Stults have studied the phosphorylation sites of several proteins by analyzing 
their enzymatic digest using on-line immobilized metal affinity chromatography 
(IMAC) coupled to CE-ESI-MS [88]. A selective preconcentration of the 
phosphorylated peptides in the IMAC step enabled the achievement of low detection 
limits in the subsequent CE-MS analysis. A more complex approach was followed 
recently by Garza and Moini [83]. These authors developed a (CE-MS/MS)n method 
which utilizes the most significant advantages of CE-MS/MS, including economy of 
sample size, fast analysis time, and high separation efficiency, to increase the sequence 
coverage of complex protein mixtures. Based on these characteristics, (CE-MS/MS)n 
can be performed in which multiple CE-MS/MS subanalyses (injections followed by 
analyses) are carried out and experimental variables are manipulated during each CE-
MS/MS subanalysis in order to maximize sequence coverage. Following this strategy, 
authors could demonstrate that (CE-MS/MS)n is a practical technique since each CE-
MS/MS subanalysis consumes <10 nL, and each CE-MS/MS subanalysis takes less than 
10 min; therefore, several subanalyses can be performed in less than 1 h consuming 
only nanoliters of the sample. 
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This sequence coverage has been also explored by the direct HPLC-CE-ESI-FTICR-MS 
coupling [43]. In that work, authors performed the on-line LC-CE-MS coupling in a 
similar way as previously described by the same group [117,118]. Figure 5 shows a 
scheme of the whole set-up as well as the mechanism used to obtain the injections in the 
CE-MS instrument. The on-line LC-CE-ESI-FTCIR-MS was employed to study the 
BSA tryptic digestion product. Low detection limits were found (low pmol), while a 
high sequence coverage (93 %) was obtained using this multidimensional set-up. An 
LC-CE-MS coupling was also used to separate peptides enabling protein identification 
in complex mixtures [119]. In this case, authors concluded that a sheathless interface 
was the best choice to perform the CZE and MS coupling to analyze the fractions 
previously separated by RPLC. 
Another different approach was followed by Dovichi and co-workers [120] coupling 
two different CE separation dimensions interfaced by a pepsin microreactor that 
allowed the first protein separation, on-line protein digestion, and second separation of 
the peptides generated coupled to MS. This novel set-up was tested using cytochrome 
and myoglobin obtaining sequence coverages of 48% and 22%, respectively. 
 
6. CONCLUSIONS AND FUTURE OUTLOOKS. 
 
As it has been shown in the present work, the use of CE-MS for peptide analysis and 
peptidomics has increased in the last few years. As the number of applications increases 
each year, new developments based on this technique are also accessible. Thus, faster, 
more efficient, reliable and sensitive applications have been developed for CE-MS as 
has been shown in the present review. However, still some improvements are required 
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before this technique can be used as routine. Thus, it is expected that future research 
will be focused on the development of more efficient and robust interfaces able to 
provide higher ionization yields, including new solutions to effectively interface CE and 
MS without the addition of sheath flows by constructing more reliable and durable 
sheathless interfaces. Besides, chip-CE-MS will remain of great interest as well as the 
multidimensional approaches. The development of new devices to interface HPLC and 
CE-MS in a robust and efficient way to obtain complete orthogonal separations will 
found also great applications possibilities. Multidimensional approaches including CE-
MS will be more and more developed and their number of applications will increase, 
including the topic of the present work, peptide analysis and peptidomics in complex 
real samples. In this sense, the undoubtedly great separation capacity of 
multidimensional techniques will find a good application area in the still growing 
proteomics/peptidomics field. 
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FIGURE LEGENDS 
 
Figure 1. CE-MS analysis of polypeptide standards (500 fmol each) (1) Aprotinin 
(6517.5 Da), (2) lysozyme (14313.1 Da), (3) ribonuclease (13690.3 Da), (4)  EVQSKIG 
YGRQIIS (1732.96 Da), (5) TGSLPYSHIGSRDQIIFMVGR (2333.19 Da), (6) 
ELMTGELPYSHINNRDQIIFMVGR (2832.41 Da), (7) GIVLYELMTGELPYSHIN 
(2048.03 Da). The upper panel shows the total ion current, with the mass spectrum of 
the peptide GIVLYELMTGELPYSHIN shown as insert. Below, the same CE-MS run is 
shown in a 3-D contour-plot, with mass/charge (Y-axis) vs. time (X-axis), and the 
signal intensity color coded. [74] 
 
Figure 2. Theoretically predicted CE-ESI-MS electropherogram (A) and experimental 
CE-ESI-MS electropherogram (B) of peptides from cytochrome c digested 
enzymatically. Numbers denote the peptides resulting from the tryptic digestion while 
letters denote unexpected fragments. [47] 
 
Figure 3. Schematic diagram of the CE capillary with on-column mSPE cartridge-
sheathless ESI-MS interface. [79] 
 
Figure 4. Diagram of the microdevice with a subatmospheric electrospray interface 
developed. The expanded view shows the coupling of the ESI tip with the separation 
channel in the liquid junction. [97] 
 
Figure 5. Experimental set-up of the LC-CE-ESI-FTICRMS system. Gradient packed 
capillary LC (id = 0.2 mm) is coupled on-line to CE (id =50 µm) via an LC-CE 
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interface in PDMS. A pressure driven flow of CE electrolyte, regulated by an injection 
switch, ensures independence of flows (when on) and provides injections (when off). 
An electric field for the CE separation is achieved between the negative potential at the 
inlet electrode, incorporated in the CE pressure chamber, and the grounded ESI emitter. 
Analytes are continuously sampled into the FTICRMS detector. [43] 
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Table 1. CE-ESI-MS of peptides and peptidomics using a sheathflow interface.  
Sample MS BGE Coating Sheath liquid Enrichment Sensitivity Ref 
Peptide 
standards 
Q 50 mM formic acid, 
0.88 mM 
ammonium formate 
(pH 2.6) 
 
- methanol:10 mM 
formic acid 70:30 
- n.s. [27] 
Peptide 
standards 
IT 0.2 – 0.5 M formic 
acid, 
10–25 mM NH4OH, 
10% ACN 
- Isopropanol: 
water (50:50) 
pH-mediated 
stacking 
LOD: 500 
amol (full 
scan, 
MS/MS) 
[52] 
Siderophores 
peptides 
IT 100 mmol/L 
ammonium 
bicarbonate (pH 8.0) 
 
- methanol:H2O 
25:75  with 0.05% (v/v) 
formic acid 
 
- n.s. [53] 
Pseudopeptide 
(DMTLT) 
IT / 
TOF 
46.5 mM ammonium 
hydrogen carbonate 
with 15% methanol, 
(pH 10) 
- 2-propanol/H2O (50:50 
v/v) (positive mode and 
+ 0.5% acetic acid in 
negative mode) 
- n.s. [54] 
Standard 
peptides 
IT 0.9 M ammonium 
formate/formic 
acid (pH 2.0) 
- methanol- H2O (50:50 
v/v) with 
0.05% v/v formic acid 
- n.s. [47] 
Lys-C digest IT 25mM formic acid (pH 
3.5) 
- methanol/ H2O/running 
buffer (80:15:5, v/v/v) 
- n.s. [55] 
Peptides from 
bovine Pepsin 
A 
IT 0.9 M formic acid (pH 
2.0) 
- methanol-H2O (50:50, 
v/v) with 0.05% formic 
acid 
- n.s. [56] 
Angiotensin I 
and II 
TQ 50 mM ammonium 
acetate 
Polyvinyl alcohol methanol-H2O (80:20) 
with 0.1% formic acid 
- 100 fmol [57] 
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(pH 3.0) 
γ-glutamyl-S-
ethenyl-
cysteine 
(GEC) 
IT 20 mM ammonium 
hydrogen carbonate 
(pH 7.0) 
- methanol-H2O (50:50 
v/v) 
with 0.1% v/v acetic 
acid 
- LOD: 0.021 
mg/mL 
[58] 
Alamethicins 
peptides 
IT / 
TOF 
12.5 mM 
ammonium formate in 
methanol 
- 2-propanol-H2O (1 : 1, 
v/v) with 1% 
formic acid 
- n.s. [59] 
Human urine 
peptides 
TOF 0.25 M formic acid 
(20% v/v ACN) 
- 7:3 v/v 
H2O/isopropanol with 
0.5% v/v 
formic acid 
- 25 fmol 
(for 
standards) 
[60] 
Enkephalin 
peptides 
IT 
 
500 mM formic acid 
(pH 2.5) 
Polybrene 
(PB) and 
poly(vinyl 
sulfonate) (PVS) 
ACN–H2O–formic 
acid (75:25:0.1 v/v/v) 
- LOD (S/N = 
3): 10–90 
fmol 
[61] 
Standard 
peptides and 
tryptic digest 
IT 100mM ammonium 
formate (pH 3.0) 
- 50% methanol, 49% 
H2O and 1% acetic acid
Field enhanced 
sample injection 
nM [62] 
aspartyl 
tripeptides 
IT 200 mM formic acid 
(pH 2.9) 
- isopropanol:H2O (1:1) - n.s. [63] 
Protein digest  0.5 M formic acid Pepsin coated 
photopolymerized 
solgel monolith 
5 mM ammonium 
acetate in 50% (v/v) 
methanol/H2O 
Online protein 
digestion 
n.s. [64] 
Bioactive 
peptide 
hormones 
TOF 50mM of acetic acid 
and 50mM of formic 
acid (pH 2.85) 
- 60:40 (v/v) 
2-propanol–H2O with 
0.05% (v/v) of formic 
acid 
- n.s. [65] 
Standard 
peptides 
IT 1.3 mM ammonium 
acetate/acetic acid and 
- methanol-H2O (50:50 
v/v) containing 0.05% 
- Shown: 0.1-
02 mg/ml 
[66] 
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130 mM 
ammonium 
formate/formic acid  
(pH 2.41) 
v/v formic 
acid 
 
Cytochrome c 
digest 
Q 150 mM acetic acid 
and 55 mM formic acid 
(pH 4.0) 
Polyacrilamide 50% v/v Isopropanol , 
0.5% v/v acetic 
acid/formic acid 
Transient ITP Shown: 14 
nmol/l 
[67] 
Biomarker 
peptides 
TOF 
IT 
QTOF 
FITCR 
30% methanol, 0.5% 
formic 
acid 
- 0.5% v/v formic acid in 
water 
- n.s. [45] 
Opioid 
peptides 
TOF 50mM acetic acid–
50mM formic acid (pH 
3.5) 
- 60:40 
(v/v) 2-propanol:H2O 
with 0.05% (v/v) of 
formic acid. 
- Shown: 200 
ng/ml 
[68] 
Angiotensin II, 
Leuenkephalin 
Q N-[carbamoylmethyl]-
2-aminoethanesulfonic 
acid (ACES) (pH 7.4) 
- 20mM of acetic acid in 
50:50 (v/v) 
methanol:H2O 
SPE LOD: ng/ml [69] 
Bradykinin, 
substance P, 
glutation 
IT 50 mM of acetic acid 
and 50 mM of formic 
acid (pH 2.5) 
- 80:20 v/v methanol/ 
H2O with 0.1% v/v of 
acetic acid (positive 
ionization) or 60:40 v/v 
isopropanol/H2O with 
0.5% v/v of 
ammonia (negative 
ionization) 
- LOD: 1 - 10 
mg/L. 
 
[70] 
Standard 
peptides 
TOF 10mM formic acid. poly-LA 313, 
polymer 
20% of 10mM formic 
acid and 80% of 
isopropanol 
- LOD: 0.3–
2.5 μM 
[71] 
Standard IT 20/40/40 - 0.1% formic acid in Stacking Shown: 10-9 [72] 
 38 
peptides and 
Cytochrome c 
digests 
acetonitrile/100 mM 
HCOONH4, pH 
3.0/water (v/v/v) 
50% 
Methanol (v/v) 
M) 
Bacteria 
peptides 
IT 10 mM ammonium 
acetate (70%) and 10 
mM acetic acid (30%) 
(pH 4.8) 
poly(vinyl 
alcohol) 
50% Methanol with 
0.5% 
acetic acid 
- n.s. [73] 
Standard 
peptides 
Q 50mM 
formic acid (pH 2.75) 
- 100% methanol 
with 0.2% formic acid 
- LOD: 5 
pmol 
[48] 
Urine and 
serum 
polypeptides 
TOF 30% methanol, 0.5% 
formic acid, 69.5% 
H2O 
- 30% methanol and 
0.5% formic acid 
- Shown: 500 
fmol 
[74] 
Hemodialysis 
fluids peptides 
TOF 30% methanol, 0.5% 
formic acid, 69.5% 
water 
- 30% methanol, 0.5% 
formic acid 
- n.s. [75] 
Peptide 
hormones 
TOF 50 mM of 
acetic acid and 50 mM 
of formic acid (pH 
2.85) 
- 60% 2-propanol, 0.05% 
v/v formic acid 
- LOD: 1 to 4 
μg/mL. 
[76] 
Angiotensin 
peptides 
QTOF  - Methanol - Shown: 10-4 
M 
[40] 
Microbial 
marker 
peptides 
IT 10 mM ammonium 
acetate (70%) and 10 
mM acetic acid (30%) 
(pH 4.8) 
poly(vinyl 
alcohol) 
50% methanol 
containing 0.5% acetic 
acid 
- n.s. [77] 
Angiotensin, 
transferrin 
 Carrier ampholytes - H2O/methanol/acetic 
acid (50/49/1) 
- LOD: 
0.22μM 
[51] 
Protein digests IT  siloxanediol-
polyacrylamide 
0.5% acetic acid in 
methanol/H2O (80/20, 
v/v) 
- n.s. [50] 
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Polypeptides n.s. 30%(v/v) 
methanol/0.5%(v/v) 
formic acid in H2O 
 
- 30%(v/v) 
methanol/0.5%(v/v) 
formic acid in H2O 
 
- n.s. [78] 
 
n.s.: data not shown in the reference 
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Table 2. CE-ESI-MS of peptides and peptidomics using a sheathless interface. 
Sample MS BGE Coating Enrichment Sensitivity Ref 
Peptide standards TQ 1-5%  acetic acid - - LOD: ca. 115 fmol [30]  
[Glu1]-
fibrinopeptide B 
IT 1 M acetic acid (pH 2.4) - - LOD (S/N=5): 900 
amol 
[79] 
Human serum 
peptides 
TOF 60 mM 
acetic acid in 20% 
methanol (pH 3.2) 
MAPTAC Stacking LOD: 10-100 nM in 
serum 
[80] 
Angiotensin 
II, Gonadorelin 
TQ 25 mM formic acid in 5% 
v/v methanol-H2O (pH 
2.3) 
3-aminopropyl-
triethoxysilane 
Off-line SPE 
On-line 
preconcentration
LOD: pM [28] 
Standard peptides TOF 16 mM acetic 
acid-ammonium acetate 
(pH 3) 
MAPTAC - n.s. [81] 
Angiotensin II, 
insulin, 
gonadorelin 
TQ 25 mM formic acid in 5% 
methanol 
- On-line 
preconcentration
Shown: 1 ng/ml [82] 
Peptide standards FITCR 10 mM 
acetic acid/ ACN 75:25 
PolyE-323 LC-CE coupling Limit of identification 
0.3 μM 
 
[43] 
Protein digest 
 
QTOF 0.05% Polybrene in 0.1% 
acetic acid 
- - Shown: 200 fmol [83] 
BSA digest TOF 5 mM acetic acid in 25% 
ACN. 
PolyE-323 
 
- Shown: 2 fmol [84] 
Angiotensin, 
Substance P 
TOF 1:1 50 mM formic 
acid/ammonium acetate 
buffer (pH 2.8) and 
methanol 
poly(vinyl 
alcohol) 
- n.s. [85] 
Cytochrome c IT 0.1% acetic acid Aminopropyl - n.s. [86] 
 41 
digest trimethoxysilane 
Extracellular 
matrix peptides 
TOF 0.5 M ammonium 
formate in H2O/methanol 
(40/60; v/v) (pH 2.2) 
- - n.s. [87] 
O-glycosylated 
peptides 
QTOF 50mM 
aqueous + 40% methanol 
ammonium 
acetate/ammonium 
hydroxide (pH 12) 
- - n.s. [39] 
 
a- and b-casein 
digests 
IT 0.1% acetic acid/10% 
methanol solution 
- - Shown: 500 fmol [88]  
Peptide standards IT 1.0 M acetic acid, pH 2.4 - - LOD: 500 amol [89]  
Peptide standards TOF 20 mM 
ammonium acetate in 
20% v/v acetonitrile (pH 
4.4) 
Monolithic 
column 
- n.s. [90]  
 
n.s.: data not shown in the reference 
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Table 3. CE-ESI-MS of peptides using a liquid junction interface. 
Sample MS BGE Coating Enrichment Sensitivity Ref 
peptide 
standards 
TOF 5 mM acetic acid with 
20% ACN 
N-Trimethoxysilylpropyl-N,N,N-
trimethylammonium chloride 
  [91] 
bradykinin, 
angiotensin I, 
neurotensin, 
Leu-enkephalin
IT 50 mM ammonium 
formate (pH 2.8) 
polyvinyl alcohol 
(PVA) 
- LOD: below 
200 ng/mL 
[37] 
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Table 4. Peptide analysis by on-chip CE-ESI-MS. 
Sample MS BGE Coating Sheath liquid Enrichment Sensitivity Ref 
Standard 
peptides 
Q 50mM formic acid (pH 
2.5) 
SMIL 50mM formic acid 
(pH 2.5) 
  [92] 
Tripeptides Q 50 mM acetic acid–
ammonium acetate buffer 
(pH 5.7) with 30% (v/v) 
ACN 
- 50 mM acetic acid–
ammonium acetate 
buffer (pH 5.7) with 
30% (v/v) 
ACN 
Stacking Shown: 100 
ppm 
[93] 
Standard 
peptides 
TOF 75% ACN, 25% 10 mM 
acetic acid 
PolyE-323 Sheathless - Shown: 1 
μg/ml 
[94] 
Tryptic digests IT aminocaproic acid/acetic 
acid (pH 4.4) 
- Liquid junction (1% 
(v/v) acetic acid in 
50% (v/v) 
methanol/H2O) 
- n.s. [95] 
Peptide 
standards 
TQ 1 M acetic 
acid 
Lupamin Sheathless - n.s. [96] 
Angiotensin IT 20 mM 6-aminocaproic 
acid (pH 4.4) 
PVA 1% v/v acetic acid in 
50% v/v methanol 
- n.s. [97] 
 
n.s.: data not shown in the reference 
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